Zinman B, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, Tarp-Johansen MJ, Araki E., PIONEER 8 Investigators
All GLP-1 agonists carry a precautionary label about thyroid C-cell tumors based on rodent studies, though this has not been confirmed in humans
Therefore, the development of efficient and biocompatible drug delivery systems (DDS) is crucial to realizing the full clinical potential of PROTAC therapy
Train harder
Lobular cancers are often missed during routine screening, which can result in larger, more advanced tumors when they are finally detected and diagnosed, said Jit Saini, MD, Chief Medical Officer of the Pharmaceutical Diagnostics (PDx) division of GE HealthCare